- Active Ingredients
Product Documentation
-
View RMM (Bosentan Patient Alert Card)
Last updated on this site: 20 Sep 2022
Initial upload
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaintBosentan Accord 125mg Film-coated Tablets
- PL Number:
- 20075/0383
- MA Holder:
- Accord Healthcare Limited
- Product Classification:
-
POM
- Product Status:
- Active
Product Documentation
-
View Summary of Product Characteristics (SmPC- Bosentan Accord 125mg Film-coated Tablets)
Last updated on this site: 20 Feb 2026
To update the SmPC and package leaflet in-line with the reference product (Tracleer 62.5/125 mg film-coated tablets; EU procedure number: EMEA/H/C/000401/PSUR/0000257801).
View Patient Information Leaflet (PIL- Bosentan Accord 62.5, 125mg Film-coated Tablets)Last updated on this site: 20 Feb 2026
To update the SmPC and package leaflet in-line with the reference product (Tracleer 62.5/125 mg film-coated tablets; EU procedure number: EMEA/H/C/000401/PSUR/0000257801).
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaint
For any further assistance, please get in touch.